How AI is streamlining cell and gene therapy manufacturing
Artificial intelligence (AI) could deliver substantially greater efficiencies in cell and gene therapy manufacturing and enable more patients to benefit from vital treatments. We examine how the technology is advancing production in specific areas and why data is critical.
